Acadia Pharmaceuticals | ACAD - Trade Debtors


Acadia Pharmaceuticals reported $139.44M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
ALKERMES USD 355.11M 1.22M Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Corcept Therapeutics USD 69.63M 5.06M Sep/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
Eisai JPY 224.06B 4.08B Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Incyte USD 895.89M 53M Sep/2025
J&J USD 17.61B 235M Sep/2025
Moderna USD 1.05B 589M Sep/2025
Neurocrine Biosciences USD 728M 132.3M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Prothena USD 5.16M 0 Dec/2023
PTC Therapeutics USD 203.07M 6.94M Sep/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025